'en:cca protocol'
(id=7141784 ; fe=en:cca protocol ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=355 creation date=2017-06-25 touchdate=2025-05-13 07:30:25.000) ≈ 7 relations sortantes
- en:cca protocol --
r_associated #0: 39 / 1 ->
en:epirubicin
n1=en:cca protocol | n2=en:epirubicin | rel=r_associated | relid=0 | w=39
- en:cca protocol --
r_associated #0: 32 / 0.821 ->
en:antineoplastic combined chemotherapy protocols
n1=en:cca protocol | n2=en:antineoplastic combined chemotherapy protocols | rel=r_associated | relid=0 | w=32
- en:cca protocol --
r_associated #0: 31 / 0.795 ->
en:carboplatin
n1=en:cca protocol | n2=en:carboplatin | rel=r_associated | relid=0 | w=31
- en:cca protocol --
r_associated #0: 27 / 0.692 ->
en:cyclophosphamide
n1=en:cca protocol | n2=en:cyclophosphamide | rel=r_associated | relid=0 | w=27
- en:cca protocol --
r_associated #0: 20 / 0.513 ->
cyclophosphamide
n1=en:cca protocol | n2=cyclophosphamide | rel=r_associated | relid=0 | w=20
- en:cca protocol --
r_associated #0: 20 / 0.513 ->
épirubicine
n1=en:cca protocol | n2=épirubicine | rel=r_associated | relid=0 | w=20
- en:cca protocol --
r_associated #0: 2 / 0.051 ->
en:therapeutic or preventive procedure
n1=en:cca protocol | n2=en:therapeutic or preventive procedure | rel=r_associated | relid=0 | w=2
| ≈ 14 relations entrantes
- cyclophosphamide ---
r_associated #0: 72 -->
en:cca protocol
n1=cyclophosphamide | n2=en:cca protocol | rel=r_associated | relid=0 | w=72
- en:cyclophosphamide ---
r_associated #0: 68 -->
en:cca protocol
n1=en:cyclophosphamide | n2=en:cca protocol | rel=r_associated | relid=0 | w=68
- en:epirubicin ---
r_associated #0: 35 -->
en:cca protocol
n1=en:epirubicin | n2=en:cca protocol | rel=r_associated | relid=0 | w=35
- épirubicine ---
r_associated #0: 35 -->
en:cca protocol
n1=épirubicine | n2=en:cca protocol | rel=r_associated | relid=0 | w=35
- en:antineoplastic combined chemotherapy protocols ---
r_associated #0: 20 -->
en:cca protocol
n1=en:antineoplastic combined chemotherapy protocols | n2=en:cca protocol | rel=r_associated | relid=0 | w=20
- en:carboplatin ---
r_associated #0: 20 -->
en:cca protocol
n1=en:carboplatin | n2=en:cca protocol | rel=r_associated | relid=0 | w=20
- cyclope (oeil) ---
r_associated #0: 15 -->
en:cca protocol
n1=cyclope (oeil) | n2=en:cca protocol | rel=r_associated | relid=0 | w=15
- Cyclophosphamide ---
r_associated #0: 10 -->
en:cca protocol
n1=Cyclophosphamide | n2=en:cca protocol | rel=r_associated | relid=0 | w=10
- carboplatine ---
r_associated #0: 10 -->
en:cca protocol
n1=carboplatine | n2=en:cca protocol | rel=r_associated | relid=0 | w=10
- en:cyclops eye ---
r_associated #0: 10 -->
en:cca protocol
n1=en:cyclops eye | n2=en:cca protocol | rel=r_associated | relid=0 | w=10
- Épirubicine ---
r_associated #0: 10 -->
en:cca protocol
n1=Épirubicine | n2=en:cca protocol | rel=r_associated | relid=0 | w=10
- cyclopeptide ---
r_associated #0: 5 -->
en:cca protocol
n1=cyclopeptide | n2=en:cca protocol | rel=r_associated | relid=0 | w=5
- cyclophiline ---
r_associated #0: 5 -->
en:cca protocol
n1=cyclophiline | n2=en:cca protocol | rel=r_associated | relid=0 | w=5
- cyclophorie ---
r_associated #0: 5 -->
en:cca protocol
n1=cyclophorie | n2=en:cca protocol | rel=r_associated | relid=0 | w=5
|